Chang, H.-S.; Kim, Y.; Lee, S.Y.; Yun, H.J.; Chang, H.-J.; Park, K.C.
Anti-Cancer SERCA Inhibitors Targeting Sorafenib-Resistant Human Papillary Thyroid Carcinoma. Int. J. Mol. Sci. 2023, 24, 7069.
https://doi.org/10.3390/ijms24087069
AMA Style
Chang H-S, Kim Y, Lee SY, Yun HJ, Chang H-J, Park KC.
Anti-Cancer SERCA Inhibitors Targeting Sorafenib-Resistant Human Papillary Thyroid Carcinoma. International Journal of Molecular Sciences. 2023; 24(8):7069.
https://doi.org/10.3390/ijms24087069
Chicago/Turabian Style
Chang, Hang-Seok, Yonjung Kim, So Young Lee, Hyeok Jun Yun, Ho-Jin Chang, and Ki Cheong Park.
2023. "Anti-Cancer SERCA Inhibitors Targeting Sorafenib-Resistant Human Papillary Thyroid Carcinoma" International Journal of Molecular Sciences 24, no. 8: 7069.
https://doi.org/10.3390/ijms24087069
APA Style
Chang, H.-S., Kim, Y., Lee, S. Y., Yun, H. J., Chang, H.-J., & Park, K. C.
(2023). Anti-Cancer SERCA Inhibitors Targeting Sorafenib-Resistant Human Papillary Thyroid Carcinoma. International Journal of Molecular Sciences, 24(8), 7069.
https://doi.org/10.3390/ijms24087069